Two‐year outcomes on bone density and fracture incidence in patients with T2DM randomized to bariatric surgery versus intensive medical therapy

Objective To determine the 2‐year outcomes of Roux‐en‐Y gastric bypass (RYGB) and sleeve gastrectomy (SG) vs. intensive medical therapy (IMT) on lean body mass, total bone mass, and bone mineral density (BMD) measures from the STAMPEDE trial. Methods 54 subjects (BMI: 36 ± 1 kg/m2, age: 48 ± 4 years...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Obesity (Silver Spring, Md.) Md.), 2015-12, Vol.23 (12), p.2344-2348
Hauptverfasser: Maghrabi, Adam H., Wolski, Kathy, Abood, Beth, Licata, Angelo, Pothier, Claire, Bhatt, Deepak L., Nissen, Steven, Brethauer, Stacy A., Kirwan, John P., Schauer, Philip R., Kashyap, Sangeeta R.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Objective To determine the 2‐year outcomes of Roux‐en‐Y gastric bypass (RYGB) and sleeve gastrectomy (SG) vs. intensive medical therapy (IMT) on lean body mass, total bone mass, and bone mineral density (BMD) measures from the STAMPEDE trial. Methods 54 subjects (BMI: 36 ± 1 kg/m2, age: 48 ± 4 years) with type 2 diabetes (T2DM) (HbA1c: 9.7 ± 2%) were randomized to IMT, RYGB, or SG and underwent DXA at baseline and at 1 and 2 years. Results At 2 years, the reduction in BMI was similar after RYGB and SG and was greater than IMT (P 
ISSN:1930-7381
1930-739X
DOI:10.1002/oby.21150